11504826 - Reagents Antibodies anti-ZnT8

This tender, identified by the reference number 11504826, concerns the procurement of specific laboratory reagents: anti-ZnT8 antibodies. ZnT8 (Zinc Transporter 8) is a protein primarily found in the pancreas and is involved in insulin secretion. Antibodies against ZnT8 are often used in research and diagnostic settings, particularly in the study of autoimmune diabetes, such as Type 1 Diabetes, where anti-ZnT8 antibodies can be a biomarker for the disease. Therefore, this tender is for the acquisition of these specialized biological reagents for use in a laboratory, likely for research purposes, diagnostic testing, or quality control. The procurement aims to ensure the availability of high-quality, reliable anti-ZnT8 antibodies that meet specific technical requirements, such as purity, specificity, and validated performance. The tender documents will detail the required specifications, quantities, and any necessary certifications or documentation. The successful supplier will be expected to provide these critical reagents in a timely manner to support ongoing scientific or diagnostic activities.

This is a supplies contract in the Research, health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 17,000.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the Research sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.